NEW YORK (GenomeWeb) – Cepheid announced today that its qualitative HIV-1 assay has achieved CE-IVD status. The assay, called Xpert HIV-1 Qual, runs on the firm's GeneXpert platform and detects nucleic acid of the virus from blood samples in around 90 minutes.